- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Uranium Resources, Inc. (NASDAQ:URRE) reports an update on its activities and its financial results for the third quarter of 2010, which ended September 30, 2010.
Uranium Resources, Inc. (NASDAQ:URRE) reports an update on its activities and its financial results for the third quarter of 2010, which ended September 30, 2010.
The press release is quoted as saying:
Don Ewigleben, President and CEO of Uranium Resources, noted, “The first nine months of 2010 have been a dynamic and rewarding time for the Company. We have made measurable progress on all fronts, as we have continued to deliver on our strategic initiatives. Last week, we completed the sale of 8,222,500 shares of common stock which provided net proceeds of approximately $9.0 million. As a result, we have further strengthened our balance sheet with the requisite capital to fund our growth strategy.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.